News Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Email Alerts Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go Advanced Search Keywords Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Aug 7, 2006 Insmed Inc. to Webcast 2006 Second Quarter Financial Results Conference Call, Tuesday, August 8, 2006 at 4:30 p.m. (ET) Jul 31, 2006 Phyton Biotech Signs Development Agreement With Insmed Jul 19, 2006 Insmed Inc. to Webcast 2006 Second Quarter Financial Results Conference Call, Tuesday, August 8, 2006 at 4:30 p.m. (ET) Jul 11, 2006 Insmed to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference Jul 5, 2006 European Medicines Agency Validates Insmed's Regulatory Application For Marketing IPLEX(TM) in Europe Jul 5, 2006 Court Decision Means That Patent Dispute between Insmed and Tercica and Genentch Will Have to Be Resolved at Trial Jun 27, 2006 Insmed Presents Positive IPLEX(TM) Data At ENDO 2006 Jun 22, 2006 Insmed Endocrine Society 2006 Update; Insmed Will Report Efficacy of IPLEX(TM) in Patients with Severe Insulin Resistance; Company Also to Present Data on the Unique Pharmacokinetics of IPLEX Jun 13, 2006 Court Dismisses Baseless Unfair Business Practices Lawsuit That Was Brought Against Insmed Jun 9, 2006 Insmed Provides Update on IPLEX(TM) Launch; Company Shares Details on Payer Usage Program and Pricing Show 5102550100 per page«1…51525354555657…69» Stay In The Loop Want to stay up to date on our news, events, and filings? Set up your email alerts. Sign Up View the latest Insmed Investor Presentation Download